30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Protagenic Therapeutics Inc (PTIX)

Track

Stock chart
Ticker: PTIX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Arrow Alexander K.
Chief Financial Officer
1 purchase — total 6,480 USD
Buy 12 Oct 2023
Value US$1,307,665.77 | Price 395.64 | Shares 40,714
Buy 18 May 2022
Value US$663,924.77 | Price 377.77 | Shares 13,648
Buy 17 May 2022
Value US$16,330.00 | Price 0.71 | Shares 23,000
Buy 30 Apr 2021
Value US$2,290.00 | Price 2.29 | Shares 1,000
Buy 29 Apr 2021
Value US$2,290.00 | Price 2.29 | Shares 1,000
Buy 17 Jun 2016
Value US$75,263.75 | Price 1.25 | Shares 60,211
Buy 13 Dec 2010
Value US$3,674.22 | Price 2.09 | Shares 1,758
Buy 13 Dec 2010
Value US$624.00 | Price 2.08 | Shares 300
Buy 13 Dec 2010
Value US$1,177.83 | Price 2.07 | Shares 569
Buy 13 Dec 2010
Value US$148.00 | Price 2.00 | Shares 74
Buy 13 Dec 2010
Value US$2,654.66 | Price 1.99 | Shares 1,334
Buy 13 Dec 2010
Value US$1,782.00 | Price 1.98 | Shares 900
Buy 13 Dec 2010
Value US$524.02 | Price 1.97 | Shares 266
Buy 10 Dec 2010
Value US$9,500.00 | Price 1.90 | Shares 5,000
Buy 10 Dec 2010
Value US$6,263.21 | Price 1.79 | Shares 3,499
Buy 10 Dec 2010
Value US$170.00 | Price 1.70 | Shares 100
Buy 10 Dec 2010
Value US$164.00 | Price 1.64 | Shares 100
Buy 10 Dec 2010
Value US$978.00 | Price 1.63 | Shares 600
Buy 10 Dec 2010
Value US$480.00 | Price 1.60 | Shares 300
Buy 10 Dec 2010
Value US$318.00 | Price 1.59 | Shares 200
Buy 21 Dec 2009
Value US$3,225.60 | Price 0.60 | Shares 5,376
Buy 14 Dec 2009
Value US$342,888.41 | Price 0.65 | Shares 527,683
Buy 9 Dec 2009
Value US$14,704.49 | Price 0.67 | Shares 21,947
Buy 8 Dec 2009
Value US$56,988.84 | Price 0.66 | Shares 86,386
Buy 19 Nov 2009
Value US$21,250.00 | Price 0.85 | Shares 25,000
Buy 16 Nov 2009
Value US$42,925.00 | Price 0.85 | Shares 50,500
Buy 13 Nov 2009
Value US$42,920.00 | Price 0.86 | Shares 50,000
Buy 12 Nov 2009
Value US$9,435.00 | Price 0.85 | Shares 11,100
Buy 25 Nov 2008
Value US$29,290.00 | Price 1.17 | Shares 25,000
Buy 29 Aug 2008
Value US$100,655.00 | Price 4.03 | Shares 25,000
Buy 13 Jun 2008
Value US$42,968.00 | Price 4.30 | Shares 10,000
Buy 11 Jun 2008
Value US$43,601.00 | Price 4.36 | Shares 10,000
Buy 10 Jun 2008
Value US$43,107.00 | Price 4.31 | Shares 10,000
Buy 5 Jun 2008
Value US$42,071.00 | Price 4.21 | Shares 10,000
Buy 2 Jun 2008
Value US$140,000.00 | Price 4.00 | Shares 35,000
Buy 30 May 2008
Value US$159,750.50 | Price 4.56 | Shares 35,000
Buy 30 Nov 2007
Value US$175,000.00 | Price 14.00 | Shares 12,500
Buy 12 Feb 2007
Value US$3,492,000.00 | Price 0.01 | Shares 360,000,000
Buy 12 Feb 2007
Value US$3,492,000.00 | Price 0.01 | Shares 360,000,000
Sale 24 Oct 2006
Value US$11,724.44 | Price 0.02 | Shares 586,222
Sale 24 Oct 2006
Value US$46,897.74 | Price 0.02 | Shares 2,344,887
Sale 24 Oct 2006
Value US$351,733.04 | Price 0.02 | Shares 17,586,652
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-13 2023-10-12 B Purchase
Arrow Alexander K.

Chief Financial Officer

Officer
40,714 +4.0%
395.64
US$1,307,666 		40,714 +4.0% 395.64 US$1,307,666
2022-05-18 2022-05-18 B Purchase
Arrow Alexander K.

Chief Financial Officer

Officer
13,648 -45.8%
377.77
US$663,925 		13,648 -45.8% 377.77 US$663,925
2022-05-18 2022-05-17 B Purchase
Arrow Alexander K.

Chief Financial Officer

Officer
42,821 +24.5%
462.85
US$3,016,917 		42,821 +24.5% 462.85 US$3,016,917
2021-05-03 2021-04-30 B Purchase
Arrow Alexander K.

Chief Financial Officer

Officer
1,000 +0.8%
2.29
US$2,290 		1,000 +0.8% 2.29 US$2,290
2021-05-03 2021-04-29 B Purchase
Arrow Alexander K.

Chief Financial Officer

Officer
1,000 +0.8%
2.29
US$2,290 		1,000 +0.8% 2.29 US$2,290
2016-08-18 2016-06-17 B Purchase ARMEN GARO H

See Remarks

Executive Director Large shareholder
60,211 +1.4%
1.25
US$75,264 		60,211 +1.4% 1.25 US$75,264
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
1,758 +0.4%
2.09
US$3,674 		1,758 +0.4% 2.09 US$3,674
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
300 +0.1%
2.08
US$624 		300 +0.1% 2.08 US$624
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
569 +0.1%
2.07
US$1,178 		569 +0.1% 2.07 US$1,178
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
74 +0.0%
2.00
US$148 		74 +0.0% 2.00 US$148
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
1,334 +0.3%
1.99
US$2,655 		1,334 +0.3% 1.99 US$2,655
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
900 +0.2%
1.98
US$1,782 		900 +0.2% 1.98 US$1,782
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
266 +0.1%
1.97
US$524 		266 +0.1% 1.97 US$524
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
5,000 +1.1%
1.90
US$9,500 		5,000 +1.1% 1.90 US$9,500
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
3,499 +0.8%
1.79
US$6,263 		3,499 +0.8% 1.79 US$6,263
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
100 +0.0%
1.70
US$170 		100 +0.0% 1.70 US$170
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
100 +0.0%
1.64
US$164 		100 +0.0% 1.64 US$164
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
600 +0.1%
1.63
US$978 		600 +0.1% 1.63 US$978
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
300 +0.1%
1.60
US$480 		300 +0.1% 1.60 US$480
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
200 +0.0%
1.59
US$318 		200 +0.0% 1.59 US$318
2010-01-07 2009-12-21 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
5,376 +0.2%
0.60
US$3,226 		5,376 +0.2% 0.60 US$3,226
2010-01-07 2009-12-14 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
527,683 +20.4%
0.65
US$342,888 		527,683 +20.4% 0.65 US$342,888
2010-01-07 2009-12-09 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
21,947 +0.9%
0.67
US$14,704 		21,947 +0.9% 0.67 US$14,704
2010-01-07 2009-12-08 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
86,386 +3.5%
0.66
US$56,989 		86,386 +3.5% 0.66 US$56,989
2010-01-07 2009-11-19 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
25,000 +1.0%
0.85
US$21,250 		25,000 +1.0% 0.85 US$21,250
2010-01-07 2009-11-16 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
50,500 +2.1%
0.85
US$42,925 		50,500 +2.1% 0.85 US$42,925
2010-01-07 2009-11-13 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
50,000 +2.1%
0.86
US$42,920 		50,000 +2.1% 0.86 US$42,920
2010-01-07 2009-11-12 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
11,100 +0.5%
0.85
US$9,435 		11,100 +0.5% 0.85 US$9,435
2008-11-26 2008-11-25 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
25,000 +1.1%
1.17
US$29,290 		25,000 +1.1% 1.17 US$29,290
2008-09-03 2008-08-29 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
25,000 +1.1%
4.03
US$100,655 		25,000 +1.1% 4.03 US$100,655
2008-06-17 2008-06-13 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.30
US$42,968 		10,000 +0.4% 4.30 US$42,968
2008-06-12 2008-06-11 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.36
US$43,601 		10,000 +0.4% 4.36 US$43,601
2008-06-12 2008-06-10 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.31
US$43,107 		10,000 +0.4% 4.31 US$43,107
2008-06-09 2008-06-05 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.21
US$42,071 		10,000 +0.4% 4.21 US$42,071
2008-06-02 2008-06-02 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
35,000 +1.6%
4.00
US$140,000 		35,000 +1.6% 4.00 US$140,000
2008-06-02 2008-05-30 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
35,000 +1.6%
4.56
US$159,750 		35,000 +1.6% 4.56 US$159,750
2007-12-03 2007-11-30 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
12,500 +0.8%
14.00
US$175,000 		12,500 +0.8% 14.00 US$175,000
2007-03-06 2007-02-12 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
360,000,000 +516.1%
0.01
US$3,492,000 		360,000,000 +516.1% 0.01 US$3,492,000
2007-03-06 2007-02-12 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
360,000,000 +516.1%
0.01
US$3,492,000 		360,000,000 +516.1% 0.01 US$3,492,000
2006-10-27 2006-10-24 S Sale Banon Sid

Former Director
586,222 -90.8%
0.02
US$11,724 		586,222 -90.8% 0.02 US$11,724
2006-10-27 2006-10-24 S Sale CHAZEN JEROME A Non-Executive Director
2,344,887 -90.8%
0.02
US$46,898 		2,344,887 -90.8% 0.02 US$46,898
2006-10-26 2006-10-24 S Sale KIER ISAAC Non-Executive Director
17,586,652 -90.8%
0.02
US$351,733 		17,586,652 -90.8% 0.02 US$351,733
Explore more

More insider trading research around Protagenic Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America